Association of ACAT1-positive vesicles with late endosomes/lysosomes in cholesterol-rich human macrophages

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 7, 2010, Pages 740-750

  Lei, Xiaofeng ^a   Fujiwara, Yukio ^a   Chang, Catherine Cy ^b   Chang, Ta Yuan ^b   Takeya, Motohiro ^a   Sakashita, Naomi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

ACAT1; Cholesterol; Cholesterol esterification; Human macrophage; Late endosome lysosome

Indexed keywords

AMINE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; U18666A; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CELL FRACTIONATION; CELL ISOLATION; CHOLESTEROL ESTERIFICATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG INHIBITION; ENDOSOME; ENZYME ACTIVITY; ENZYME LOCALIZATION; FLUORESCENCE MICROSCOPY; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOADSORPTION; IMMUNOELECTRON MICROSCOPY; LYSOSOME; MACROPHAGE; OUTCOME ASSESSMENT; PHAGOSOME; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSPORT VESICLE;

EID: 77955832660     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.4416     Document Type: Article

References (32)

1. Lusis AJ: Atherosclerosis. Nature, 2000; 407: 233-241
2. Glass CK, Witztum JL: Atherosclerosis: The Road Ahead. Cell, 2001; 104: 503-516
3. Libby P, Clinton SK: The role of macrophages in atherogenesis. Curr Opin Lipidol, 1993; 4: 355-363
4. Kruth HS, Jones NL, Huang W, Zhao B, Ishii I, Chang J, Combs CA, Zhang WY: Macropinocytosis is the endocytic pathway that mediates macrophage foam cell transformation with native low density lipoprotein. J Biol Chem, 2005; 280: 2352-2360
5. Buono C, Li Y, Waldo SW, Kruth HS: Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL. J Lipid Res, 2007; 48: 2411-2418
6. Sugii S, Reid PC, Ohgami N, Du H, Chang TY: Distinct endosomal compartments in early trafficking of low density lipoprotein-derived cholesterol. J Biol Chem, 2003; 278: 27180-27189
7. Chang TY, Chang CC, Ohgami N, Yamauchi Y: Cholesterol sensing, trafficking, and esterification. Annu Rev Cell Dev Biol, 2006; 22: 129-157
8. Rudel LL, Lee RG, Cockman TL: Acyl coenzyme A: cholesterol acyltransferase type 1 and 2: structure and function in atherosclerosis. Curr Opin Lipidol, 2001; 12: 121-127
9. Buhman KF, Accad M, Farese RV: Mammalian acyl-CoA: cholesterol acyltransferases. Biochem Biophys Acta, 2000; 1529: 142-154
10. Sakashita N, Chang CC, Lei XF, Fujiwara Y, Takeya M, Chang TY: Hybrid organelles containing trans-Golgi network marker and ACAT1 in cholesterol-loaded macrophages. J Lipid Res, 2009; in press
11. Sakashita N, Miyazaki A, Takeya M, Horiuchi S, Chang CC, Chang TY, Takahashi K: Localization of human acylcoenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues. Am J Pathol, 2000; 156: 227-236
12. Yagyu H, Kitamine T, Osuga J, Tozawa R, Chen Z, Kaji Y, Oka T, Perrey S, Tamura Y, Ohashi K, Okazaki H, Yahagi N, Shionoiri F, Iizuka Y, Harada K, Shimano H, Yamashita H, Gotoda T, Yamada N, Ishibashi S: Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem, 2000; 275: 21324-21330
13. Accad M, Smith SJ, Newland DL, Sanan DA, King LE, Linton MF, Fazio S, Farese RV: Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. J Clin Invest, 2000; 105: 711-719
14. Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, Sawanobori K, Watanabe T, Miyazaki A: A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis, 2007; 191: 290-297
15. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, Schoenhagen P, Waters DD, Pepine CJ, Crowe TD, Davidson MH, Deanfield JE, Wisniewski LM, Hanyok JJ, Kassalow LM: ACAT Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) Investigators. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med, 2006; 354: 1253-1263
16. Li L, Pownall HJ: Regulation of acyl-coenzyme A: cholesterol acyltransferase (ACAT) synthesis, degradation, and translocation by high-density lipoprotein 2 at a low concentration. Arterioscler Thromb Vasc Biol, 2000; 20: 2636-2642
17. Chang CC, Chen J, Thomas MA, Cheng D, Del Priore VA, Newton RS, Pape ME, Chang TY: Regulation and immunolocalization of acyl-coenzyme A:cholesterol acyltransferase in mammalian cells as studied with specific antibodies. J Biol Chem, 1995; 270: 29532-29540
18. Miyazaki A, Sakashita N, Lee O, Takahashi K, Horiuchi S, Hakamata H, Morganelli PM, Chang CC, Chang TY: Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol, 1998; 18: 1568-1574
19. Desjardins M, Huber LA, Parton RG, Griffiths G: Biogenesis of phagolysosomes proceeds through a sequential series of interactions with endocytic apparatus. J Cell Biol, 1994; 124: 677-688
20. Sakashita N, Miyazaki A, Chang CC, Chang TY, Kiyota E, Satoh M, Komohara Y, Morganelli PM, Horiuchi S, Takeya M: Acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) is induced in monocyte-derived macrophages: in vivo and in vitro studies. Lab Invest, 2003; 83: 1569-1581
21. Faust JR, Goldstein JL, Brown MS: Receptor-mediated uptake of low density lipoprotein and utilization of its cholesterol for steroid synthesis in cultured mouse adrenal cells. J Biol Chem, 1977; 252: 4861-4871
22. Underwood KW, Andemariam B, McWilliams GL, Liscum L: Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J Lipid Res, 1996; 37: 1556-1568
23. Cadigan KM, Spillane DM, Chang TY: Isolation and characterization of Chinese hamster ovary cell mutants defective in intracellular low density lipoprotein-cholesterol trafficking. J Cell Biol, 1990; 110: 295-308
24. Flannagan RS, Cosío G, Grinstein S: Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat Rev Microbiol, 2009; 7: 355-366
25. Chang TY, Reid PC, Sugii S, Ohgami N, Cruz JC, Chang CC: Niemann-Pick Type C disease and intracellular cholesterol trafficking. J Biol Chem, 2005; 280: 20917-20920
26. Liscum L, Faust JR: Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick Type C fibroblasts. J Biol Chem, 1987; 262: 17002-17008
27. Liscum L: Pharmacological inhibition of the intracellular transport of low-density lipoprotein-derived cholesterol in Chinese hamster ovary cells. Biochim Biophys Acta, 1990; 1045: 40-48
28. Tabas I: Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Invest, 2002; 110: 905-911
29. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH: Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem, 1995; 270: 5772-5778
30. Khelef N, Soe TT, Quehenberger O, Beatini N, Tabas I, Maxfield FR: Enrichment of acyl coenzyme A: cholesterol O-acyltransferase near trans-Golgi network and endocytic recycling compartment. Arterioscler Thromb Vasc Biol, 2000; 20: 1769-1776
31. Dove DE, Su YR, Zhang W, Jerome WG, Swift LL, Linton MF, Fazio S: ACAT1 Deficiency Disrupts Cholesterol Efflux and Alters Cellular Morphology in Macrophages. Arterioscler Thromb Vasc Biol, 2005; 25: 128-134
32. Robenek H, Schmitz G: Ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular. Arteriosclerosis, 1988; 8: 57-67